Repression by nuclear hormone receptors (NHRs) plays an important role in development, immune response and cellular function. We review mechanisms of how NHRs act as repressors of gene transcription either by direct contact with basal transcription factors or through recruitment of cofactors and enzymic activities that modulate chromatin accessibility. We describe also the role and biochemical mechanism of the cognate hormone that switches a NHR from a transcriptional silencer into an activator. This includes data from crystal structure, functional receptor domain analyses and the role of co-repressors in chromatin modification and remodelling. Furthermore, the comparison of negative response elements with classical response elements unravels the role of co-repressors in this context. We also describe the inhibition of the nuclear factor B and Jun/Fos pathway by NHRs, as well as the molecular mechanism of anti-hormone therapies. Anti-hormones are commonly used in breast and prostate cancer therapy to inhibit cancer proliferation through repression of the oestrogen or androgen receptor, respectively. Here we provide a comprehensive overview of the various mechanism of NHR repression.
Introduction
More and more studies are revealing that gene silencing is just as important as gene activation. Through these studies many interesting new aspects of the molecular action of gene control have emerged. Nuclear hormone receptors (NHRs) represent a large family of ligand-regulated transcription factors. They can bind to their cognate hormone-response elements on DNA and regulate, activate or repress the expression of their target genes. They can be roughly divided into receptors that bind to steroids, receptors that bind to non-steroids and orphan receptors for which no ligand is yet known.
Interestingly, hormone-bound NHRs can have both activation and repression functions. When bound to their response element they activate target genes; however, they can also repress genes through inhibition of other signalling pathways, which is termed crosstalk [1] . Unliganded NHRs act either as gene silencers or are transcriptionally inactive. Unliganded receptors for steroids, such as the androgen receptor (AR), are localized in the cytoplasm and become activated by hormone, which leads to dissociation of heat-shock factors from the receptor and translocation to the nucleus [2] . In contrast, unliganded non-steroid NHRs such as thyroid hormone receptor (TR), retinoic acid receptor (RAR) or most orphan receptors are located in the nucleus, where they bind to their response elements. These non-steroid NHRs silence target genes in an active manner by recruitment of co-repressors [3] . Gene silencing by NHRs is a very important and crucial function in vivo since aberrant silencing leads to disease and developmental abnormalities. In this chapter we review the different levels and mechanisms of repression by NHRs.
Gene-silencing by co-repressors
NHRs have a tripartite structure. The DNA-binding domain is highly conserved, consists of two zinc-finger motifs, and separates the receptor Nterminus from its C-terminus. Both TRs and RARs silence gene transcription 
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Silencing DNA in the absence of hormone through a silencing domain (Figure 1 ) in the receptor's C-terminus, a region overlapping the ligand-binding domain (LBD) [2] . One mechanism of repression is through binding of co-repressors. Corepressors are non-DNA-binding cofactors, which are located in the nucleus and harbour an autonomous silencing domain [3] . These factors interact with the silencing domain in a hormone-sensitive manner. Binding of the cognate hormone induces a conformational change in the receptor resulting in dissociation of co-repressors and relief of gene silencing [2] . In the following we summarize characteristics of selected co-repressors for NHRs focusing on the best characterized co-repressor class, SMRT (silencing mediator for RAR and TR)/NCoR (nuclear receptor co-repressor), which can be considered as a paradigm for co-repressor action.
Various co-repressors for NHR have been identified that can be divided by their mode of interaction with NHR. Co-repressors such as SMRT, NCoR, Alien, Hairless (Hr) and SMRTER (SMRT-related ecdysone receptor-interacting factor) interact in a ligand-sensitive manner with NHR. Ligand binding leads to their dissociation from the receptor. SUN-CoR (small unique nuclear receptor co-repressor) and PSF (polypyrimidine tract binding protein-associated splicing factor) are co-repressors that bind constitutively to NHR, while RIP140 (receptor-interacting protein 140) and LCoR (ligand-dependent nuclear receptor co-repressor) bind only to liganded receptors [4] [5] [6] [7] [8] . Here, we briefly provide a few characteristics of these co-repressors.
SMRT/NCoR
The co-repressors first characterized for NHRs are SMRT and NCoR, which bind to the silencing domains of TRs, RARs and other NHRs only in the absence of ligand [9] . NCoR and SMRT show very similar domain structures and functionality, and can be separated into a functional C-terminal part interacting with NHRs and an N-terminal part which mediates the repression signal to both the basal transcription machinery and to chromatin. Two specific nuclear receptor interaction domains (IDs) within SMRT/NCoR have been identified. In analogy to the Leu-Xaa-Xaa-Leu-Leu (LXXLL) sequence motifs found in co-activators (see Chapter 6 in this volume), similar hydrophobic motifs, termed ⌽XX⌽⌽ (where ⌽ is any hydrophobic amino acid) or CoRNR (co-repressor/nuclear receptor box) motifs in the IDs, have been shown to mediate interactions with NHRs [10] . It is discussed that each ID contacts one nuclear receptor LBD within the NHR dimers. Interestingly, the IDs differ in their affinities for specific receptors. RAR and TR, for example, have higher affinities for ID1, whereas RXR (retenoid X receptor) shows a preference for ID2 [11] . Notably, recent evidence shows that NCoR is more relevant for TR-mediated gene silencing as SMRT [12] .
Overexpression of SMRT increases receptor-mediated silencing in the absence of hormone. Both NCoR and SMRT are complexed with other proteins that have histone deacetylase (HDAC) activity, which is thought to render chromatin more condensed and therefore becomes less accessible. In addition, TR-, SMRT-and NCoR-mediated silencing are, at least in part, sensitive to the HDAC inhibitor trichostatin A. This indicates that NHRs with silencing function recruit HDAC activity for target gene repression.
The crystal structures of LBDs from different NHRs reveal a structure that consists of 12 ␣-helices. A region within Helix 1, the CoR box, is crucial for the recruitment of SMRT and NCoR, while a binding surface formed by Helices 3, 4 and 5 is needed for co-repressor as well as co-activator binding [11] . A key player in the regulation of the hormone-sensitive interaction is Helix 12 (Figures 1 and 2 ). In the unliganded state, Helix 12 protrudes away from the core structure of the LBD. However, ligand binding induces a rotation of Helix 12 towards the LBD core, now forming a lid on the hormonebinding cavity. Amino acid substitutions that abrogate this conformational change can impair co-repressor release after hormone binding [13] . In addition, NHRs that lack Helix 12 have constitutive silencing function, despite binding ligand [14] . This strongly suggests that Helix 12 regulates co-repressor release and association of co-activators upon hormone binding.
SMRT and NCoR mediate the repression function by at least three transferable repression domains, which show no homology with each other. This fact suggests several non-redundant and simultaneous modes of repression by SMRT/NCoR which are discussed below [11] .
In Drosophila, SMRTER, a functional analogue of SMRT/NCoR, has been identified. Failure of ecdysone receptor to silence genes and to bind SMRTER leads to developmental defects [15] . 
Alien
Alien shows a hormone-sensitive interaction with TR [16] [17] [18] . Interestingly, Alien exhibits different receptor specificity from the SMRT/NCoR class due to its lack of interaction with RAR or RXR. Alien interacts in the absence of ligand with TR, the vitamin D receptor and with the orphan receptor DAX-1. Alien shows no significant homologies to the SMRT/NCoR class but harbours ⌽XX⌽⌽ motifs. Interestingly, Alien is highly conserved, showing 90% identity between human and Drosophila, indicating an essential evolutionarily conserved function. Similarly, Drosophila Alien interacts specifically with Drosophila NHRs, such as ecdysone receptor/Svp (seven-up) [16] . Recently, it was shown that the expression of Alien is controlled by thyroid hormone in the developing rat brain and in cultured cells, suggesting a negative-feedback mechanism between TR and its own co-repressor. Thus the reduction of corepressor levels may represent a control mechanism of TR-mediated gene silencing [19] .
Hr
Hr was recently also identified as a co-repressor for TR, using HDAC activity for repression. Interestingly, Hr shows tissue-and development-specific expression and, similar to Alien, its expression is also controlled by thyroid hormone in brain [20] .
SUN-CoR
SUN-CoR which exhibits hormone-independent interaction with NHRs may modulate both ligand and unliganded NHR action [4] .
PSF
Similarly, PSF is a co-repressor that binds hormone-independently to TR and RXR, mediating repression through recruitment of Sin3A. In contrast with SMRT/NCoR, Alien and Hr, PSF binds to the DNA-binding domains of NHRs [5] .
RIP140
RIP140 represents a third co-repressor category that is able to repress agonistbound NHRs such as the glucocorticoid receptor or RAR/RXR. Interaction with NHRs is mediated by nine LXXLL receptor-interacting motifs, usually found in co-activators for interaction with NHRs [6, 7] .
LCoR
In a similar way, LCoR is recruited to agonist-bound NHRs through a single LXXLL motif and represses the activity of oestrogen receptor ␣, progesterone receptor and vitamin D receptor. Interestingly, LCoR functions by recruitment of HDAC activity and CtBP (C-terminal-binding protein) [8] .
Thus, co-repressors exhibit ligand-sensitive, ligand-independent and ligand-dependent interactions with NHRs, and are therefore very important for modulating the activity of NHRs.
NHR action on chromatin
NHRs are able to repress genes through changing chromatin structure and accessibility. The basic structural units of chromatin are the nucleosomes, which consist of DNA wrapped around histone octamers (Figure 3 ). Histone H1 functions as a linker between the nucleosomes that can lead to an even more compacted organization. Chromatin is not static, instead covalent histone modifications and alterations of the nucleosomal array are two major processes that can influence the accessibility of the transcriptional machinery and thereby the expression of genes.
Histone modifications take place on specific residues most commonly located at the N-terminal tails of the histones and include methylation, phosphorylation and acetylation. It is thought that acetylated histones induce a more open chromatin structure (Figure 3) . HDACs remove the acetyl group NHRs recruit co-repressors that in turn recruit factors with enzymic activities such as HDACs or histone methyltransferases. Both enzymic activities modify the N-termini of the histones, termed histone tails. HDACs remove acetyl groups that were originally transferred by histone acetyltransferases. Thereby it is thought that histones bind more tightly to DNA and thus lead to a more compact and less accessible chromatin, indicated here as a shorter distance between nucleosomes. Methyltransferases methylate histone tails at lysine and arginine residues. Depending on the specific methylated residue and on how many methyl groups have been transferred, methylation can lead to transcriptional silencing, e.g. through recruitment of heterochromatin-associated protein 1 (HP1; see text). Right-hand side: NHRs interact with factors of the basal transcription machinery of RNA polymerase II (RNA pol II) for both gene activation and gene silencing. Transcription factor IIB (TFIIB) and TATA-binding protein (TBP) interaction with nuclear receptors in the absence of ligand were shown to be associated with gene repression. Furthermore, co-repressors were also shown to interact with the basal transcription machinery. It is thought that the recruitment of basal transcription factors is impaired and/or the activity of the transcriptional PIC (pre-initiation complex) is inhibited. TAF, TBP-associated factor. from the lysine residues, inducing a more compact structure consistent with findings that repressed genes are mostly hypoacetylated.
Recruitment of HDACs by co-repressors
Co-repressors for NHRs are associated with HDACs [21] . They interact directly with HDAC II family members (HDACs 4-7) . In addition, association of co-repressors with class I HDAC complexes have been reported. The Sin3A-Sin-associated protein (SAP) complex harbours the SAPs, the retinoblastomaassociated proteins 46 and 48 (RbAp46 and RbAp48), the HDACs 1 and 2, and the Sin3A protein, which acts as a scaffold for the complex. The class I family member HDAC 3 forms a stable complex with SMRT in vivo. Importantly, SMRT and NCoR are activating cofactors for HDAC 3. Activation of HDAC 3 is mediated by the deacetylase-activating domain ('DAD') that includes one of two SANT motifs found in both SMRT and NCoR. The C-terminal SANT motif functions as part of a histone-interaction domain, which enhances repression by increasing the affinity of the deacetylase-activating domain HDAC 3 enzyme for histone substrate and by its ability to inhibit histone acetyltransferase activity [22, 23] . So far all co-repressors known for NHRs are associated with HDAC activity, suggesting a major role for gene silencing through histone deacetylation and chromatin compaction.
Recruitment of histone methyltransferases by NHRs
Methylation of the N-terminal histone tails has also been associated with gene repression (Figure 3 ). This modification is carried out by histone methyltransferases [24] . SUV39H1 (the human variant of suppressor of variegation 3-9) is involved in NHR-mediated repression [25] . It methylates Lys-9 of histone H3 and interacts with unliganded TR, facilitating TRmediated repression in an histone-methyltransferase-activity-dependent manner. NHRs induce a set of different histone modifications such as acetylation, phosphorylation and methylation. Repression by unliganded TR is accompanied by an increase in His-3-Lys-9 methylation, a decrease in methylation of His-3-Lys-4 and a decrease in phosphorylation of Ser-10 of histone H3. Furthermore, because methylation by SUV39H1 generates a binding motif for heterochromatin-associated protein 1 (HP1), it may promote a higher-order chromatin structure.
Recruitment of nucleosome-remodelling activity by NHR
Also important is the organization and positioning of the nucleosomes. Chromatin-remodelling complexes induce ATP-dependent changes in the position of the histone octamer relative to DNA by a transient disruption of the histone-DNA interaction [26] . Interestingly, the nucleosome remodelling and histone deacetylation (NURD) complex combines HDAC activity and chromatin-remodelling activity. It is proposed that disruption of the nucleosomal array facilitates access of the HDAC component to the histone tails. Studies on TR-dependent repression showed the involvement of the NURD complex [27] , which contains the methyl-binding proteins MBD 2 and 3, MTA 2 and the ATP-remodelling component Mi-2 [21] . Both Sin3A and NURD complexes are constitutively associated with chromatin and may thereby be involved in TR-mediated repression by establishing and maintaining a more global histone deacetylation [25] . In addition, NCoR/SMRT form several protein complexes associated with HDAC 3. NCoR, for example, is in a complex containing both HDAC 3 and subunits of a remodelling complex, including Brg1 (brahma-related gene-1), the mammalian Snf2-related ATPase-containing activity and BAF (Brg1-associated factor). The remodelling activity of this complex is also implicated in NHR-mediated repression [28] .
Thus NHR-mediated repression can be achieved by recruitment of enzymic complexes that structurally remodel or chemically modify nucleosomes.
Gene silencing by NHRs through interference with the basal transcription machinery
Another mechanism by which NHRs mediate gene silencing is by directly targeting the basal transcriptional machinery (Figure 3) . The TR silencing domain interacts with the basal transcription factor TFIIB only in the absence of ligand, suggesting that this interaction contributes to gene silencing [29] . In addition, unliganded TR inhibits the formation of a functional pre-initiation complex (PIC) in in vitro chromatin-free assays. In agreement with this, TR inhibits transcription only at an early step during PIC assembly, while pre-assembled PICs are unaffected by TR [30, 31] . Using stepwise pre-assembled PICs, it has been shown that TR␣ targets either the TATA-binding protein (TBP)/TFIIA or the TBP/TFIIA/TFIIB steps of PIC assembly for repression. Furthermore these TR-TBP interactions can be inhibited by thyroid hormone [32] .
NCoR/SMRT have also been reported to interact with TFIIB and TBPassociated factors (TAFs) [33, 34] . Furthermore, overexpression of NCoR prevents a functional interaction of TFIIB with TAF II 32, which is a critical step in the assembly of the transcription-initiation complex. This suggests that NCoR also represses gene activity by disturbing the assembly of an intact, functional initiation complex.
Thus, co-repressor activity, as well as NHR-mediated gene silencing, acts on multiple levels, from the basal transcription machinery to chromatin and higher-order structures.
Hormone receptor inactivation by anti-hormones
Anti-hormones are important synthetic pharmaceutical agents that are by definition antagonists of hormone action. They are used in therapies against hormone-dependent tumours, including prostate and breast cancer. Drug targets are the AR in prostate cancer and oestrogen receptor in breast cancer therapy. Anti-hormones bind to the LBD of hormone receptors and inhibit the action of the receptors (Figure 4) . In most cases, steroid receptors are inactivated upon anti-hormone binding leading to an inhibition of target-gene transcription, resulting in a block of tumour proliferation [35] .
A number of studies suggest that co-repressors are responsible for this effect. An interaction with co-repressors in the presence of anti-hormones has been found for progesterone, glucocorticoid, oestrogen and androgen receptors [36] [37] [38] [39] (Figure 4) . Crystal structure data show that Helix 12 shifts towards the N-terminus of the antagonist-bound LBD [11] . This shift might not only disrupt co-activator interaction, but might also expose the surface for co-repressor binding. Notably, recent findings for AR suggest that co-repressors are able to bind to the N-terminus of AR to mediate receptor inhibition [37] , indicating that co-repressors bind to both C-termini and N-termini of NHRs. These findings provide a molecular explanation for how anti-hormones inhibit steroid receptors: through recruitment of co-repressors.
Negative response elements
NHRs mediate their genomic effects on transcription by binding to specific DNA elements known as hormone-response elements (HREs). Classically, hormone binding to receptors leads to hormone-dependent gene activation. However, on response elements known as negative HREs (nHRE), binding of NHRs leads to a ligand-dependent repression of target gene transcription ( Figure 5) . A common observation is that nHREs are located in the vicinity of the transcriptional start site of a gene or are located downstream of the TATA box [40] .
Most of the negative response elements share the common feature that in the absence of hormone type II receptors, such as TR, they bind to these elements to constitutively activate transcription. In contrast, hormone leads to repression of transcription by both class I and class II receptors bound on these negative response elements.
While much work has focused on HREs, only little is known mechanistically about nHREs. On one nHRE it has been shown that the liganded TR recruits HDAC 2 [41] . In addition, it was recently shown that SMRT can function as a co-activator for TR␣ in the absence of thyroid hormone on another nHRE, suggesting that allosteric changes resulting from binding of TR to different HREs can dictate whether a cofactor acts as a co-activator or co-repressor [42] .
Transcriptional repression by NHR through inhibition of signalling pathways via crosstalk
NHRs can also alter expression of genes that do not contain any HREs through interference with other transcription factors ( Figure 6 ). A very well- studied example is the observation that several nuclear receptors, such as TR, RAR or glucocorticoid receptor, can act as ligand-dependent transrepressors of activator protein 1 (AP-1; Jun/Fos) activity, and reciprocally that AP-1 can inhibit transactivation by NHRs [1, 40] . It is considered that many antiproliferative effects of NHR ligands are mediated by their anti-AP-1 activity. In a similar manner, glucocorticoid receptor can mutually interfere with nuclear factor B activity (NF-B), which is a molecular explanation for the anti-inflammatory and immunosuppressive effects of glucocorticoids. Several mechanisms have been proposed for inhibition of AP-1 and NF-B including direct contact, competition for common transcriptional mediators and involvement of c-Jun N-terminal kinase or other unknown factors [1, 40] . Recently, a novel mechanism for inhibition of cAMP-responsive genes by TR was revealed. Here, liganded TR inhibits the transcriptional activation mediated by CREB, the cAMP-response-element-binding protein [43] . 
Impact of gene repression by NHRs on development and disease
Several observations indicate an important impact of gene repression by NHRs in development and disease. The repression function of TR is implicated in amphibian development. There is evidence for an essential dual role of TR in this process. In premetamorphic tadpoles TR is expressed prior to the production of endogenous thyroid hormone, whereas during metamorphosis production of thyroid hormone allows metamorphosis. Premature exogenous treatment of tadpoles with thyroid hormone leads to premature metamorphosis, suggesting that TR represses metamorphosis in its unliganded form, indicating that TR silences target genes while hormone binding leads to activation of TR target genes involved in metamorphosis [44] . In Xenopus, RAR-mediated silencing is critical for head formation. Expression of dominant-negative co-repressors results in malformations similar to early treatment of retinoic acid [45] . NCoR-knockout mice show an altered pattern of transcription, which is associated with developmental blocks at specific points in the central nervous system, erythrocyte and thymocyte differentiation [46] . Aberrant gene silencing is associated with some diseases. An oncogenic form of the TR, v-ErbA, lacking Helix 12, contributes to avian erythroleukaemia by repression of target genes. A point mutant that lacks the ability to repress transcription and to interact with SMRT also abolishes oncogenic transformation. Repression plays also a major role in the syndrome of thyroid hormone resistance, which is caused by mutations in the LBD of TR (see Chapter 12 in this volume). The severity of the resistance directly correlates with the repression function of TR, as mutations of TR found in patients impair the ability of co-repressors to dissociate from the receptor [11, 40, 47] . In addition, abnormal fusion variants of RAR␣, created by chromosomal translocations with either the promyelocytic leukaemia or the PLZF (promyelocyte leukaemia zinc finger) locus, block myeloid differentiation, resulting in acute promyelocytic leukaemia. This differentiation block correlates with the ability of the fusion proteins to repress transcription and to recruit nuclear receptor co-repressors. In promyelocytic leukaemia-RAR␣ patients treatment with retinoic acid, which abolishes repression and leads to co-repressor-receptor dissociation, relieves this differentiation block resulting in remission of the disease. However, patients with a PLZF-RAR translocation are not treatable with retinoic acid because there is a second recruitment for co-repressors in the PLZF part that is unaffected by retinoic acid [11, 40] . The orphan nuclear receptor DAX-1 (dosage-sensitive hypoplasia congenital on X-chromosome) is implicated in the pathogenesis of adrenal hypoplasia congenita and hypogonadism. DAX-1 inhibits steroidogenic factor 1-mediated transcription and this inhibition is mediated by the C-terminal silencing domain of DAX-1. In most DAX-1 mutants from adrenal hypoplasia congenita patients this region is affected. DAX-1 mutants fail to interact with Alien and have lost their silencing function. This suggests an important role for Alien in the pathogenesis mediated by DAX-1-mutant patients [18, 48] . These examples together establish the importance of repression by NHRs in disease and development.
Conclusions
In recent years, it has become more and more evident that transcriptional repression is as important as transcriptional activation in the control of gene expression. In this chapter, we have reviewed the different levels and mechanisms of repression by NHRs. Genomic effects are mediated by recruitment of co-repressors, effects on chromatin structure, contacts to the basal transcription machinery and negative response elements. In addition, repression is achieved via crosstalk with other signalling pathways, like AP-1. Thus, repression by NHRs is a complex, combinatorial, multilevel process. We are still at the beginning of understanding the complex interplay of activation and repression. Microarrays will be important tools to identify target genes silenced by NHR. Future experiments including mice model systems will reveal the biological role of the different levels of repression.
Summary

• Gene silencing by NHRs is essential for proper development.
• Aberrant gene silencing leads to disease, cancer and malformations.
• Gene silencing is mediated by inhibition of the basal transcription apparatus.
• Gene silencing is also mediated at the chromatin level by histone deacetylation, methylation and alteration of the nucleosomal array.
• NHRs repress other signalling pathways through crosstalk.
• NHR repression is a major drug target for cancer therapy (hormone antagonists and agonists, such as retinoic acid).
